Showing results (191-200 of 343) with videos related to
Sort By:
Pageof 35
American Journal of Hematology|September 29, 2011
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion geneLoredana Elia, Sara Grammatico, Francesca Paoloni, et al.Cell Proliferation|February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myelomaAlessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.Frontiers in Pharmacology|December 13, 2021
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance DatabaseLucia Gozzo, Calogero Vetro, Serena Brancati, et al.Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.Redox Biology|September 1, 2020
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomibGiuseppina Camiolo, Alessandro Barbato, Cesarina Giallongo, et al.Oncotarget|September 17, 2016
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphomaAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.Frontiers in Pharmacology|June 1, 2026
The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort studyUros Markovic, Gabriele Sapuppo, Sara Frazzetto, et al.American Journal of Hematology|December 23, 2016
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trialsMassimo Gentile, Valeria Magarotto, Massimo Offidani, et al.International Journal of Molecular Sciences|February 3, 2019
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron OverloadGiuseppina Camiolo, Daniele Tibullo, Cesarina Giallongo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma NetworkAntonio Palumbo, Patrizia Falco, Paolo Corradini, et al.Pageof 35